Peptide Regulation: What the FDA Vote Really Means
Peptide regulation is changing — but the FDA’s 2026 vote isn’t a green light. Here’s what’s safe, what’s not, and how to shop smart for peptide products.

Peptide regulation is changing — but the FDA’s 2026 vote isn’t a green light. Here’s what’s safe, what’s not, and how to shop smart for peptide products.

A 1,400-person study found yo-yo dieting quietly costs muscle even when the scale stays the same. Here’s how to break the cycle for good.

You’re doing everything right with your GLP-1 medication but the scale won’t budge. This is what GLP-1 resistance means for women with PCOS, why inflammation and dose matter, and questions to ask your doctor.

Healthy fat tissue protects your metabolism, but losing it the wrong way backfires. Here’s what makes fat cells healthy and what to track beyond the scale.

Stanford researchers used AI to discover BRP, a naturally occurring molecule that suppresses appetite like Ozempic without the nausea, vomiting, or muscle loss. Here’s how this natural Ozempic works and when it might be available.

Compounded GLP-1 drugs are often prescribed online without FDA approval — the Yale secret shopper study reveals a dangerous safety gap. Learn 5 questions to ask before accepting a prescription.

Newly diagnosed with PCOS? Discover how PCOS weight loss works — from GLP-1 medications and inositol to anti-inflammatory eating and lifestyle changes that actually work.
Ozempic feet is the latest GLP-1 side effect causing foot pain, shoe size changes, and skin issues. Learn what causes it and how to protect your feet with protein, strength training, and proper footwear.

Looking for GLP-1 alternatives? From FDA-approved pills like phentermine and Qsymia to new drugs in development targeting amylin, MC4R, and other pathways — here’s what you need to know now and what’s coming next.

New BMJ research finds weight loss drugs help drop pounds but don’t improve quality of life. Only semaglutide protects the heart. What the trade-offs mean for you.